Physician profile
Robert Ernst
NPI 1275588311
$14,904.62
in general payments reported to CMS, 2019-2025
9 companies · $12K in 2025
The $12K reported for 2025 was more than what 87% of Neuroradiology providers received nationally (typical 2025 total: $278).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $19.00 · 2022: $239 · 2023: $1,462 · 2024: $1,660 · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $11K · Food and Beverage: $2,785 · Travel and Lodging: $1,080.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $10,781.25 |
| Food and Beverage | $2,785.27 |
| Travel and Lodging | $1,080.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $12,345.05 | 2022-2025 | Intracept, Na, General - Pain Management |
| Medtronic, INC. | $1,169.23 | 2022-2025 | Intellis Adaptivestim, Kyphon Express II Kyphopak Tray, Inceptiv |
| Relievant Medsystems, INC. | $1,133.64 | 2023 | Intracept |
| Arthrex, INC. | $165.96 | 2025 | |
| Saluda Medical Americas, INC. | $24.44 | 2024 | Evoke |
| Novartis Pharmaceuticals Corporation | $19.76 | 2022 | |
| Advanced Critical Devices, INC. | $19.00 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $15.72 | 2024 | |
| Spr Therapeutics, INC | $11.82 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Ernst listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.